Home News Radio Interview with Robbert van…

Kiadis is concerned with stem cell transplantation, especially in the area of leukemia. In 2018, the product is expected to enter the European market. Before that, there are neither profits nor sales. By the end of 2017, at the beginning of 2018, the financing is secured. What are the next Milestones? Listen here to the Interview with Robbert van Heekeren regarding Kiadis’ plans for the future (Interview in English)